The Role of Insulin in Endocrinopathic Laminitis

Journal of Equine Veterinary Science

Volumn 28, Issue 10, 2008, Pages 603-607

  McGowan, Catherine ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Equine Cushing's syndrome; Equine metabolic syndrome; Glucocorticoids; Hyperinsulinemia; Laminitis

Indexed keywords

EQUIDAE;

EID: 53649087579     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jevs.2008.08.004     Document Type: Article

References (34)

1. Johnson P.J., Messer N.T., Slight S.H., Wiedmeyer C., Buff P., and Ganjam V.K. Endocrinopathic laminitis in the horse. Clin Tech Equine Pract 3 (2004) 45-56
2. Schott II H.C. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin North Am: Equine Pract 18 (2002) 237-270
3. Wilson M.G., Nicholson W.E., Holscher M.A., Sherrell B.J., Mount C.D., and Orth D.N. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. Endocrinology 110 (1982) 941-954
4. McGowan C.M., and Neiger R. Efficacy of trilostane for the treatment of equine Cushing's syndrome. Equine Vet J 35 (2003) 414-418
5. McCluskey M.J., and Kavenagh P.B. Clinical use of triamcinolone acetonide in the horse (205 cases) and the incidence of glucocorticoid-induced laminitis associated with its use. Equine Vet Educ 16 (2004) 86-89
6. Bathe A.P. The corticosteroid laminitis story: 3. The clinician's viewpoint. Equine Vet J 39 (2007) 12-13
7. Bailey S.R., and Elliott J. The corticosteroid laminitis story: 2. Science of if, when and how. Equine Vet J 39 (2007) 7-11
8. French K.R., and Pollitt C.C. Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal searation in vitro. Equine Vet J 36 (2004) 261-266
9. Tiley H.A., Geor R.J., and McCutcheon L.J. Effects of dexamethasone administration on insulin resistance and components of insulin signaling and glucose metabolism in equine skeletal muscle. Am J Vet Res 69 (2008) 51-58
10. McGowan C.M., Frost R., Pfeiffer D.U., and Neiger R. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J 36 (2004) 295-298
11. Reaven G.M. The metabolic syndrome: requiescat in pace. Clin Chem 51 (2005) 931-938
12. Reaven G.M. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 33 (2004) 283-303
13. th Annual Forum of the American College of Veterinary Internal Medicine; 1999:192-194 (abstr).
14. Johnson P.J. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am: Equine Pract 18 (2002) 271-293
15. st Annual Forum of the American College of Veterinary Internal Medicine (2003)
16. rd British Equine Veterinary Association Congress 103 (2004) (abstr)
17. Treiber K.H., Kronfeld D.S., Hess T.M., Byrd B.M., and Splan R.K. Pre-laminitic metabolic syndrome in genetically predisposed ponies involves compensated insulin resistance. J Anim Physiol Anim Nutr 89 (2005) 430-431
18. Treiber K.H., Kronfeld D.S., Hess T.M., Byrd B.M., Splan R.K., and Staniar W.B. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 228 (2006) 1538-1545
19. Geor R.J., Thatcher C.D., Pleasant R.S., Elvinger F., Gay L., and Werre S.R. Prevalence of hyperinsulinemia in mature horses: relationship to adiposity. J Vet Intern Med 21 (2007) 601 (abstr)
20. McGowan C.M., Geor R.J., and McGowan T.W. Prevalence and risk factors for hyperinsulinemia in ponies. J Vet Intern Med 22 (2008) 734 (abstr)
21. Pass M.A., Pollitt S., and Pollitt C.C. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J 26 (1998) 133-138
22. Wattle O., and Pollitt C.C. Lamellar metabolism. Clin Tech Equine Pract 13 (2004) 22-33
23. Hunt D.G., and Ivy J.L. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 93 (2002) 1638-1643
24. Huang H., Gazzola C., Pegg G.G., and Sillence M.N. Effect of corticosterone on beta-adrenoceptor density in rat skeletal muscle. J Anim Sci 76 (1998) 999-1003
25. Asplin K.E., McGowan C.M., Pollitt C.C., Curlewis J., and Sillence M.N. Role of insulin in glucose uptake in the equine hoof. J Vet Intern Med 21 (2007) 668 (abstr)
26. Hartge M.M., Unger T., and Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 4 (2007) 84-88
27. Singer G., and Granger D.N. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation 14 (2007) 375-387
28. Rattigan S., Bussey C.T., Ross R.M., and Richards S.M. Obesity, insulin resistance, and capillary recruitment. Microcirculation 14 (2007) 299-309
29. Garner H.E., Coffman J.R., Hahn J.W., Hutcheson D.P., and Tumbleson M.E. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 36 (1975) 441-444
30. Galey F.D., Whiteley H.E., Goetz T.E., Kuenstler A.R., Davis C.A., and Beasley V.R. Black walnut (Juglans nigra) toxicosis: a model for equine laminitis. J Comp Pathol 104 (1991) 313-326
31. Parsons C.S., Orsini J.A., Krafty R., Capewell L., and Boston R. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004). J Am Vet Med Assoc 230 (2007) 885-889
32. van Eps A.W., and Pollitt C.C. Equine laminitis induced with oligofructose. Equine Vet J 38 (2006) 203-208
33. Asplin K.E., Sillence M.N., Pollitt C.C., and McGowan C.M. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J 174 (2007) 530-535
34. Field J.R., and Jeffcott L.B. Equine laminitis: another hypothesis for pathogenesis. Med Hypotheses 30 (1989) 203-210